4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-019971
Chief Executive Officer sold 300,000 shares at an average $7.43 ($2,228,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-03-13 | Sale | −100,000 | $7.43 | $743,000 | 2,194,789 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2018-03-14 | Sale | −100,000 | $7.44 | $744,000 | 2,094,789 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2018-03-15 | Sale | −100,000 | $7.41 | $741,000 | 1,994,789 | D |
| Open-market sales · 300,000 sh · avg $7.43 · $2,228,000 | |||||||
Loading xslF345X03/doc4.xml…